RZH
ABBV icon

Relyea Zuckerberg Hanson’s AbbVie ABBV Stock Holding History

Relyea Zuckerberg Hanson’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.92M Sell
27,498
-339
-1% -$72.9K 0.58% 40
2026
Q1 		$6.05M Sell
27,837
-331
-1% -$73.4K 0.61% 40
2025
Q4 		$6.44M Buy
28,168
+3,522
+14% +$802K 0.65% 35
2025
Q3 		$5.71M Sell
24,646
-59
-0.2% -$12K 0.6% 36
2025
Q2 		$4.59M Buy
24,705
+391
+2% +$72.7K 0.54% 37
2025
Q1 		$5.09M Buy
24,314
+224
+0.9% +$43.5K 0.69% 31
2024
Q4 		$4.28M Buy
24,090
+13,902
+136% +$2.56M 0.58% 34
2024
Q3 		$2.01M Buy
10,188
+217
+2% +$40.5K 0.31% 49
2024
Q2 		$1.71M Buy
9,971
+135
+1% +$22.4K 0.29% 51
2024
Q1 		$1.79M Buy
9,836
+534
+6% +$92K 0.31% 46
2023
Q4 		$1.44M Buy
9,302
+248
+3% +$36.2K 0.28% 53
2023
Q3 		$1.35M Buy
9,054
+704
+8% +$103K 0.31% 50
2023
Q2 		$1.12M Buy
8,350
+495
+6% +$72.6K 0.25% 59
2023
Q1 		$1.25M Buy
7,855
+969
+14% +$148K 0.31% 52
2022
Q4 		$1.11M Buy
6,886
+947
+16% +$145K 0.32% 50
2022
Q3 		$797K Buy
5,939
+259
+5% +$37.2K 0.29% 51
2022
Q2 		$870K Buy
5,680
+46
+0.8% +$7.03K 0.32% 50
2022
Q1 		$896K Sell
5,634
-119
-2% -$17.3K 0.29% 57
2021
Q4 		$759K Buy
5,753
+566
+11% +$66.9K 0.28% 64
2021
Q3 		$560K Buy
5,187
+144
+3% +$16.5K 0.22% 73
2021
Q2 		$568K Buy
5,043
+122
+2% +$13.7K 0.23% 65
2021
Q1 		$548K Buy
4,921
+203
+4% +$21.7K 0.24% 64
2020
Q4 		$506K Sell
4,718
-10
-0.2% -$961 0.27% 64
2020
Q3 		$403K Sell
4,728
-40
-0.8% -$3.77K 0.26% 70
2020
Q2 		$468K Hold
4,768
– – 0.37% 60
2020
Q1 		$363K Hold
4,768
– – 0.4% 60
2019
Q4 		$422K Buy
+4,768
New +$396K 0.41% 56

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Relyea Zuckerberg Hanson's ABBV Position: Q2 2026 in Review

Relyea Zuckerberg Hanson reduced its AbbVie (ABBV) stake by 1.2% in Q2 2026, selling an estimated $72.9K and leaving 27,498 shares worth $6.92M. The position accounts for 0.58% of the portfolio, ranked #40.

Relyea Zuckerberg Hanson first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Relyea Zuckerberg Hanson held 27,498 shares of AbbVie worth $6.92M as of Q2 2026.
  • Relyea Zuckerberg Hanson sold 339 AbbVie shares in Q2 2026, an estimated $72.9K.
  • AbbVie made up 0.58% of Relyea Zuckerberg Hanson's portfolio in Q2 2026, its #40 holding.
  • Relyea Zuckerberg Hanson first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Relyea Zuckerberg Hanson's 13F filing for Q2 2026, filed 16 Jul 2026.